Intrinsic Value of S&P & Nasdaq Contact Us

Phreesia, Inc. PHR NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
$544.71
+6233.8%
Analyst Price Target
$27.50
+219.8%

Phreesia, Inc. (PHR) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 20 Buy, 5 Hold.

The consensus price target is $27.50 (low: $22.00, high: $33.00), representing an upside of 219.8% from the current price $8.60.

Analysts estimate Earnings Per Share (EPS) of $-1.78 and revenue of $0.39B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.51 vs est $-1.78 (missed -40.9%). 2025: actual $-1.02 vs est $-1.09 (beat +6.2%). 2026: actual $0.04 vs est $0.08 (missed -50.3%). Analyst accuracy: 54%.

PHR Stock — 12-Month Price Forecast

$27.50
▲ +219.77% Upside
Average Price Target
Based on 25 Wall Street analysts offering 12-month price targets for Phreesia, Inc., the average price target is $27.50, with a high forecast of $33.00, and a low forecast of $22.00.
The average price target represents a +219.77% change from the last price of $8.60.
Highest Price Target
$33.00
Average Price Target
$27.50
Lowest Price Target
$22.00

PHR Analyst Ratings

Buy
25
Ratings
20 Buy
5 Hold
Based on 25 analysts giving stock ratings to Phreesia, Inc. in the past 3 months
Rating breakdown
Buy
20 80%
Hold
5 20%
80%
Buy
20 analysts
20%
Hold
5 analysts
0%
Sell
0 analysts

EPS Estimates — PHR

54%
Analyst Accuracy
Inaccurate
3 years compared
Actual vs Estimate
2024 Actual –$2.51 vs Est –$1.78 ▼ 29.0% off
2025 Actual –$1.02 vs Est –$1.09 ▲ 6.6% off
2026 Actual $0.04 vs Est $0.08 ▼ 101.3% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

Revenue Estimates — PHR

97%
Analyst Accuracy
Accurate
3 years compared
Actual vs Estimate
2024 Actual $0.356B vs Est $0.390B ▼ 9.4% off
2025 Actual $0.420B vs Est $0.419B ▲ 0.2% off
2026 Actual $0.481B vs Est $0.480B ▲ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message